Skip to main content

Pearls, Challenges and Updates in Daily Gastrointestinal Pathology Practice

Original release date:
January 3, 2024
Access to this course expires on:  December 3, 2026 at 11:59 PM Pacific Time
CME 12.75

Course Description
Join four gastrointestinal (GI) pathologists as they discuss cases of commonly encountered, yet challenging areas in GI pathology. Participants will explore the GI tract from the diagnosis and assessment of dysplasia to inflammatory disorders, iatrogenic injury, neuroendocrine neoplasms, appendiceal pathology, mesenchymal tumors, and polyps. Faculty will discuss how to recognize common inflammatory conditions and their mimics, look for evidence of drug induced mucosal changes in the retrieved GI specimens, and discuss other challenging situations that may lead to diagnostic error.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Evaluate specimens from patients with inflammatory bowel disease (IBD)
  • Discuss criteria to recognize and grade dysplasia throughout the GI tract
  • Recognize and generate a wider differential diagnosis for biopsies of inflammatory disorders of the GI tract, be able to resolve these differentials, and distinguish from drug induced injury
  • Classify the neuroendocrine proliferations and neoplasms in the GI tract
  • Diagnose neoplastic lesions of the appendix and distinguish these from their mimics
  • Recognize mesenchymal tumors of the GI tract, and how to distinguish them from gastrointestinal stromal tumors (GIST) and its variants
  • Describe the spectrum of GI polyps, including mixed polyps, syndromic polyps, serrated polyps, and malignant polyps

Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the United States and Canadian Academy of Pathology and Rodger C. Haggitt Gastrointestinal Pathology Society (GIPS). The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Dipti Mahajan Karamchandani, MD, Alexandros D. Polydorides, MD, PhD, Paul E. Swanson, MD, Melissa W. Taggart, MD

The following IM Coordinator reported no relevant financial relationships: Scott Owens, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. Learners can now self-submit CME on all earned certificates. View and print your certificates by clicking here.

USCAP members receive a discount on all e-Learning courses. Not A Member? Click Here to sign up today.